In a groundbreaking Metabolomics Benchmarking study, conducted under the auspices of the National Institutes of Health (NIH), Gigantest proudly stood alongside with renowned institutions such as Pacific Northwest National Laboratory (PNNL) and the Broad Institute of MIT and Harvard.
Together, these esteemed establishments received ground tumor powder samples from a diverse array of tumor types, which were then meticulously divided and distributed equally among the three labs – Gigantest, PNNL, and Broad Institute. The objective? To compare their metabolomics analysis capabilities and determine the consistency and accuracy of their results.
Unprecedented Collaboration yields astounding metabolomics results! More than 97% of the results obtained from all three labs showcased a remarkable level of agreement. This shared success is a testament to the profound expertise in metabolomics that Gigantest brings to the field, solidifying their position as a trailblazer in the field.
This unprecedented collaboration buzzes the scientific community with excitement, fosters scientific synergy that will undoubtedly fuel further breakthroughs in the exciting realm of metabolomics. For Gigantest and its dedicated team of Scientists, this momentous achievement serves as a resounding affirmation of their unwavering pursuit of scientific excellence. As the world looks to unravel the mysteries of metabolomics, Gigantest stands at the forefront, ready to pave the way for a bright future.